The role of radiotherapy and chemotherapy in extraskeletal myxoid chondrosarcoma
Patients with distant metastases at presentation had significantly shorter survival rates than those without. Wide resection is mandatory to reduce the risk of local recurrence of localized EMCs, and the local control effect of (neo)adjuvant radiotherapy is limited. Chemotherapy has a limited effect on improving survival.
Authors
- Kanya Honoki
- Akihito Nagano (ORCID: https://orcid.org/0000-0003-0261-480X)
- Shinji Tsukamoto (ORCID: https://orcid.org/0000-0002-8419-2008)
- Akira Kawai (ORCID: https://orcid.org/0000-0003-2116-586X)
- Tomoya Masunaga
- Costantino Errani (ORCID: https://orcid.org/0000-0002-4504-2867)
Institutions
- National Cancer Centre Japan (JP)
- Istituto Ortopedico Rizzoli (IT)
- Gifu University (JP)
- Nara Medical University (JP)
Publication Details
- Journal
- Journal of Orthopaedic Surgery and Research
- Published
- 2025-08-30
- DOI
- https://doi.org/10.1186/s13018-025-06245-6
- Primary Topic
- Bone Tumor Diagnosis and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00